BioPalace is transforming how medical innovation is funded by unlocking biotech royalties as an accessible, investable asset class. Our mission is to democratize access to high-value royalty streams, previously reserved for institutions and insiders, and empower a broader community of investors to participate in the success of breakthrough therapies.

Through our platform, individuals and institutions can invest directly in the future cash flows of approved and near-commercial biotech products. This nondilutive model provides critical capital to life sciences companies while offering investors exposure to uncorrelated, income-generating assets backed by real-world health impact.

At BioPalace, we believe the future of medicine should be built collectively. By enabling royalty-based investments, we’re not only fueling the development of transformative treatments but also creating a transparent, data-driven marketplace where innovation and impact go hand in hand.

BioPalace

Org chart

Teams

Offices